PHARMAC SOUTH
PHARMAC SOUTH is the most premier, high-powered Contract Manufacturing, Pharmaceutical & Nutraceutical Exhibition & Conference. Participants include manufacturers and trade professionals from industries as diverse as Pharma Machinery, Analytical Instruments, Lab Equipment, Herbal and Cosmetics. It is one of the must-attend events for the pharma & allied sectors.
PHARMAC SOUTH provides a unique forum to understand Industry trends and markets, dialogue with key technical and regulator personnel and associated stakeholders and compare notes with major suppliers of products and services in the pharmaceuticals industry.
- Pharmaceutical Bulk Drugs, Veterinary Drugs, Additives, Intermediates.
- Pharmaceutical Formulation, API
- Pharmaceutical Machinery / Printing & Packaging.
- Pharma Ancillary & Utility Services & Maintenance. (Water & HVAC systems)
- Nutraceutical Product/ Dietary Supplements
- Contract Manufacturers
- Contract Research Organizations (CROS).
- Ayurvedic / Herbal Products.
- Software For Pharmaceutical Industry & Management.
- Bio-pharmaceuticals/ Bio Lab Instruments & Equipment.
- Pharmaceutical Engineering / Refrigeration / Clean Room Technology.
- Analytical Laboratory Supplies (instruments, Glassware, Lab Reagents -Chemicals).
- Banks / Financial Sectors Focusing On Pharma Industry.
- Trade Promotion Bodies-technical Publications / Trade Association / Media / Publications.
- Patent / Trade Mark Lawyers
Looking for chemical products? Let suppliers reach out to you!
MEDEXPO KENYA 2023
2026-07-15
-
Life Sciences Industry Overview
The coverage spans the global life sciences industry across pharmaceuticals and food & nutrition, tracking the shift from lowest-cost sourcing to supply continuity, quality, and risk management, along with product trends and the growing edge of differentiated, globally capable players.Published in: June.2026
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Strides Pharma Reports Strong Q2 as Net Profit Surges 82%
-
India Strengthens Drug Approval Oversight with Expanded CDSCO Powers
-
Pfizer Sues Metsera and Novo Nordisk Over Rival Obesity Drug Strategy
-
Cipla CEO Calls Tirzepatide a High-Science Product with Strong Market Outlook
-
Pfizer Seen Holding Strategic Edge in Bidding Battle for Metsera
-
Canada Issues Non-Compliance Notice to Dr. Reddy’s on Semaglutide Generic
-
Novo Nordisk Enters High-Stakes Bidding War with Pfizer for Metsera
-
U.S. Health Chief Says No Evidence Linking Tylenol to Autism
-
Merck and Eisai Halt Late-Stage Trial for Liver Cancer Therapy
-
Lilly Eyes Fast-Track Approval for Oral Weight-Loss Drug in U.S.
Recommend Reading
-
Zydus Lifesciences Blocked by Delhi High Court in Cancer Biosimilar Case $9.3 Billion Opdyta Patent Dispute Intensifies
-
Sun Pharma’s Secret Sauce: Solve the Specific, Win the Market
-
The Oral GLP-1 Cage Match: Orforglipron vs Rybelsus
-
Novartis Boosts 2025 Earnings Forecast as US Tariff Risks Loom $23 Billion Investment and $10 Billion Buyback Unveiled
-
Bristol Myers’ Reblozyl Misses Main Goal in Cancer Anemia Study $1.77 Billion Drug Faces Setback but Shows Some Benefits
-
Cyclohexane Market Supply and Demand Balance, Operating Steadily in China
-
In August, the Chinese epoxy resins market continues to rise slightly in stability
-
Weak and Volatile Ethanol Market in China
-
Weak and Volatile Methanol Market in China in July
-
Premium Global Chemical Sourcing Requests (23 - 27 Feb, 2026)